APA citiranje

Tibalinda, P., Sempombe, J., Shedafa, R., Masota, N., Pius, D., Temu, M., & Kaale, E. (2016). Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design. Heliyon.

Citação norma Chicago

Tibalinda, Prosper, Joseph Sempombe, Raphael Shedafa, Nelson Masota, Dickson Pius, Mary Temu, and Eliangiringa Kaale. "Formulation Development and Optimization of Lamivudine 300 Mg and Tenofovir Disoproxil Fumarate (TDF) 300 Mg FDC Tablets By D-optimal Mixture Design." Heliyon 2016.

MLA citiranje

Tibalinda, Prosper, et al. "Formulation Development and Optimization of Lamivudine 300 Mg and Tenofovir Disoproxil Fumarate (TDF) 300 Mg FDC Tablets By D-optimal Mixture Design." Heliyon 2016.